References
- Merlo M, Cannatà A, Gobbo M, et al. Evolving concepts in dilated cardiomyopathy. Eur J Hear Fail. 2017;20:228–239.
- Merlo M, Pivetta A, Pinamonti B, et al. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Hear Fail. 2014;16:317–324.
- Castelli G, Fornaro A, Ciaccheri M, et al. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management. Circ Hear Fail. 2013;6:913–921.
- Merlo M, Caiffa T, Gobbo M, et al. Reverse remodeling in dilated cardiomyopathy: insights and future perspectives. IJC Hear Vasc. 2018;18:52–57.
- Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet. 2010;375:752–762.
- Bobbo M, Pinamonti B, Merlo M, et al. Comparison of patient characteristics and course of hypertensive hypokinetic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol. 2017;119:483–489.
- Stolfo D, Merlo M, Pinamonti B, et al. Early improvement of functional mitral regurgitation in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2015;115:1137–1143.
- Merlo M, Gobbo M, Stolfo D, et al. The prognostic impact of the evolution of RV function in idiopathic DCM. JACC Cardiovasc Imaging. 2016;9:1034–1042.
- Waddingham PH, Bhattacharyya S, Van Zalen J, et al. Contractile reserve as a predictor of prognosis in patients with non-ischaemic systolic heart failure and dilated cardiomyopathy: a systematic review and meta-analysis. Echo Res Pract. 2018;5:1–9.
- Lupón J, Gaggin HK, de Antonio M, et al. Biomarker-assist score for reverse remodeling prediction in heart failure: the ST2-R2 score. Int J Cardiol. 2015;184:337–343.
- Dal Ferro M, Stolfo D, Altinier A, et al. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy. Heart. 2017;103:1704 LP–1710.
- Masci PG, Schuurman R, Andrea B, et al. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging. 2013;6:790–799.
- Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR working group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92.
- Höke U, Khidir MJH, van der Geest RJ, et al. Relation of myocardial contrast-enhanced T1 mapping by cardiac magnetic resonance to left ventricular reverse remodeling after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. Am J Cardiol. 2017;119:1456–1462.
- Køber L, Thune JJ, Nielsen JC, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221–1230.
- Sohal M, Shetty A, Duckett S, et al. Noninvasive assessment of lv contraction patterns using CMR to identify responders to CRT. JACC Cardiovasc Imaging. 2013;6:864–873.
- Smiseth OA, Torp H, Opdahl A, et al. Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J. 2016;37:1196–1207.
- Merlo M, Masè M, Vitrella G, et al. Usefulness of addition of magnetic resonance imaging to echocardiographic imaging to predict left ventricular reverse remodeling in patients with non-ischemic cardiomyopathy. Am J Cardiol Published Online First. 2018;122:490–497.
- Corrado D, Basso C, Judge DP. Arrhythmogenic cardiomyopathy. Circ Res. 2017;121:784 LP–802. Available from: http://circres.ahajournals.org/content/121/7/784.abstract
- O’Mahony C, Jichi F, Pavlou M, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). Eur Heart J. 2014;35:2010–2020.